Header Logo

Connection

DAVID POPLACK to Incidence

Back to Details
This is a "connection" page, showing publications DAVID POPLACK has written about Incidence.
DAVID POPLACK
Connection Strength
0.005
Incidence
  1. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.